Global Lyme disease treatment market is anticipated to grow at a CAGR of 8.4% during the forecast period (2024-2031). The increased focus of public and private organizations on developing new drugs and devices to diagnose and treat Lyme disease is a key factor driving the global market growth.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/lyme-disease-treatment-market
Recent market developments
- In January 2023, Upstate Medical University launched a Multidisciplinary Lyme and Tick-Borne Disease Treatment Center, owing to a $898,000 federal grant from the Health Resources and Services Administration. The center centralized Upstate’s existing resources for tick-borne disease prevention.
- In January 2023, Pfizer launched a Phase III clinical trial for a new Lyme disease vaccine, VLA15, developed by Valneva in collaboration with Pfizer. The vaccine, which protects children and adults, is expected to help combat the increasing need for vaccination against the tick-borne disease.
- In February 2023, the US Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation launched Phase 2 of the LymeX Diagnostics Prize, inviting ten Phase 1 winners to participate in a virtual accelerator. The goal is to nurture the development of diagnostics for Food and Drug Administration review. The virtual accelerator provides a pathway to develop the next generation of Lyme disease diagnostics, addressing the significant lag time in detection and treatment interventions due to the current two-tier serological testing system.
Global Lyme Disease Treatment Market Report Segment
By Administration Route
- Oral
- Injectable
- Topical
By Treatment
- Medication
- Tick Removal
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online
A full report of Lyme Disease Treatment Market available @ https://www.omrglobal.com/industry-reports/lyme-disease-treatment-market
Lyme Disease Treatment Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Almirall, S.A.
- Cipla Ltd.
- Eli Lilly and Co.
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Hikma Pharmaceuticals PLC
- Lupin Pharmaceutical, Inc.
- Mayne Pharma Group Ltd.
- Merck & Co., Inc.
- Novartis AG
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
